key: cord-0078568-r5ncvsvz
authors: Gatto, Ilenia; Biagioni, Emanuela; Coloretti, Irene; Viappiani, Serena; Busani, Stefano; Girardis, Massimo
title: Difference in PaO(2)/FiO(2) between high-flow nasal cannula and Venturi mask in hypoxemic COVID-19 patients
date: 2022-05-24
journal: J Anesth Analg Crit Care
DOI: 10.1186/s44158-022-00051-w
sha: 18cb2793f054c1720c562e6e69e1398be0c59c79
doc_id: 78568
cord_uid: r5ncvsvz

The ratio between arterial blood partial pressure of oxygen and fraction of inspired oxygen (PaO(2)/FiO(2)) was largely used for grading and managing the respiratory failure in non-mechanically ventilated COVID-19. In these patients, the assessment of the true FiO(2) in the inspired mixture may be difficult with consequent inaccuracies in PaO(2)/FiO(2) assessment. In 30 severe COVID-19 patients, we observed that PaO(2)/FiO(2) values measured immediately before and after the transition from high-flow nasal cannula (HFNC) to one commercially available Venturi mask O(2) therapy were similar (bias mean value 0, standard deviation 23 mmHg). In COVID-19 patients recovering from respiratory failure, PaO(2)/FiO(2) is not different whether measured with a commercially available Venturi mask or HFNC.

During the SARS-CoV-2 pandemic, the ratio between arterial blood partial pressure of oxygen and fraction of inspired oxygen in the inspired mixture (PaO 2 /FiO 2 , mmHg) was largely used for defining the severity of the respiratory failure and its progression, for deciding the appropriate respiratory support, and, consequently, for using specific pharmacological therapy [1] . Therefore, a careful assessment of PaO 2 /FiO 2 is fundamental. As it is well known, PaO 2 /FiO 2 is not the ideal variable for measuring the PO 2 alveolar-arterial gradient because it does not consider PCO 2 and its not linear relationship with FiO 2 regardless of the alveolar-arterial gradient [2] . Moreover, PaO 2 /FiO 2 was initially proposed in mechanically ventilated patients, where FiO 2 is carefully measured. In non-mechanically ventilated patients, as patients in conventional O 2 mask or high-flow nasal cannula (HFNC), the assessment of the true FiO 2 in the inspired mixture may be problematic, specifically in dyspneic/ tachypneic patients with high inspiratory peak flow or with the mouth breathing during HFNC [3, 4] . Therefore, PaO 2 /FiO 2 values during the transition through the different methods of O 2 delivery could lead to misinterpretation of the degree of respiratory dysfunction. For the above reasons, we decided to investigate whether the transitions from HFCN and Venturi mask (VM), or vice versa, alter PaO 2 /FiO 2 values because of potential undetected differences in true FiO 2 .

Thirty consecutive patients admitted to our COVID-19 intensive care unit (ICU) because of severe respiratory failure due to SARS-CoV-2 infection and undergoing weaning from respiratory supports were included. As for internal protocol, after weaning from mechanical ventilation and SpO 2 > 90% with FiO 2 < 0.7 in HFNC (flow rate 60 L/min), the patients alternated HFNC and VM (FIAB S.p.A., model OS/60K, Florence, Italy) at the same FiO 2 levels with a progressive de-escalating time scheme. Twenty minutes after the transition from HFNC Gatto et al. J Anesth Analg Crit Care (2022) 2:23 to VM or vice versa, we collected respiratory rate (RR), mean arterial pressure, heart rate, FiO 2 , PaO 2 , the partial pressure of carbon dioxide (PaCO 2 ), and pH in the arterial blood and calculated alveolar-arterial PO 2 gradient (P(A-a)O 2 ) [5] . To evaluate the differences between HFNC and VM, analysis of variance, linear regression analysis, and Bland-Altman method were used [6] . The study was approved by the ethical committee (658/2020/ OSS*/AOUMO SIRER ID 417), and informed consent was obtained from participants.

Patients' characteristics were detailed in Table 1 . Twentynine patients received HFNC first and only one VM first. The PaO 2 /FiO 2 measured in HFNC were like those measured in VM (Table 2 ) with a significant linear relationship (R 2 = 0.51, p < 0.01). In the Bland-Altman analysis, the mean value and standard deviation of the bias were 0 and 23 mmHg (Fig. 1) . The RR and PaCO 2 values resulted to be different (p = 0.013 and p = 0.001) with RR higher and PaCO 2 lower in VM compared to HFNC (Table 2 ). In patients previously treated with HFNC, PaCO 2 was lower during VM in 25 patients (86.2%), and the difference was up to 5 mmHg in only 4 patients (13.8%).

Our data indicate that after 20 min from HFNC to VM transition and vice versa, PaO 2 /FiO 2 remain similar with only a small and not significant difference. Previous studies suggested that HFNC may improve oxygenation and decrease work of breathing compared to conventional O2 therapy [7] [8] [9] . In contrast with previous reports, our results may suggest that there may be an underestimation of FiO 2 with Venturi device yielding overestimation of PaO 2 /FiO 2 in contrast with the accurate delivery of FiO 2 with HFNC. Anyway, in this specific population under these circumstances, both these two phenomena have clinically acceptable limits of agreement. Moreover, we observed that RR differed between the two methods despite the very short period of exposure (20 min). The main part of the sample transitioned to VM after having received HFNC, so it cannot exclude a possible carryover effect for PaCO 2 in this transition. Moreover, a possible carry-over effect cannot be excluded also for PaO 2 / FiO 2 ratio. Rather than reducing work of breathing, the association of lower RR with a consensual increase of PaCO 2 supports the hypothesis that HFNC, compared to VM, could improve oxygenation with less requirement of alveolar ventilation for maintaining PaO 2 level. However, the low number of patients and the lack of assessment of the true FiO 2 limit any further speculation on this point.

In conclusion, our study demonstrated that although in HFNC and VM the FiO 2 is only estimated and may vary with the patient's respiratory pattern, PaO 2 /FiO 2 measured with a VM may be considered a reliable parameter for respiratory dysfunction evaluation in severely hypoxemic patients during the transitions from different O 2 delivery methods.

Abbreviations HFNC: High-flow nasal cannula; VM: Venturi mask; ICU: Intensive care unit; RR: Respiratory rate; P(A-a)O 2 : Alveolar-arterial PO 2 gradient; MAP: Median arterial pressure; HR: Heart rate; PaO 2 /FiO 2 : Arterial blood partial pressure of oxygen and fraction of inspired oxygen.

COVID-19 clinical management: living guidance

Relation between PaO2/ FIO2 ratio and FIO2: a mathematical description

Oxygen concentrations received from commonly used delivery systems

Essentials of Anaesthetic Equipment (Fourth Edition)

Nunn's Applied Respiratory Physiology

Measurement in medicine: the analysis of method comparison studies

High flow nasal oxygen in acute respiratory failure

High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review

Physiologic effects of high-flow nasal cannula oxygen in critical care subjects

Authors' contributions GI, BE, VS, and GM designed the study, enrolled the patients, analyzed data, and wrote the paper. BS and CI reviewed and edited the manuscript. All authors read and approved the final manuscript.

The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate The study was approved by the ethical committee (658/2020/OSS*/AOUMO SIRER ID 417), and informed consent was obtained from participants.

The authors declare that they have no competing interests. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.